skip to Main Content
Contact Us   480.314.3070 |

COVID-19 Clinical Trial Analysis

Imaging Endpoints’ COVID-19 analysis supports the detection and standardized recording of the clinical and radiological disease features consistent with the course of COVID-19 infection as well as the relevant epidemiological disease history. This data-driven approach offers a systematic means to support current and future research into therapies and vaccine candidates for COVID-19 and other novel pneumonia virus.

By including patient history related to COVID-19, this reading template supports patient-centric data analysis as well as multi-center cohort clinical trials in a platform that provides data quality, integrity and traceability. The reading platform facilitates structured data aggregation in line with official international study regulations. As research regarding COVID-19 is evolving rapidly, the template may be customized to the needs of each unique clinical trial.

For more information, contact Imaging Endpoints at info@imagingendpoints.com

Back To Top